A novel method to assess motor planning deficits in patients with parkinson's disease and mild cognitive impairment. [PDF]
Maffitt NJ+7 more
europepmc +1 more source
Neuropsychological methods in mild cognitive impairment
Valérie Hahn‐Barma+4 more
openalex +1 more source
Speech and Language Disorders Associated With 7q31 Deletions Implicating FOXP2
ABSTRACT Some 7q31 deletions encompass FOXP2, a gene long associated with speech and language disorders. Intragenic pathogenic FOXP2 variants cause FOXP2‐related speech and language disorder, which has been well characterized in the literature. Conversely, the phenotype associated with 7q31 deletions is neglected.
Lottie D. Morison+3 more
wiley +1 more source
Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinson's disease. [PDF]
Guo H+6 more
europepmc +1 more source
Regulatory aspects of mild cognitive impairment: toward a harmonized perspective
Peter J. Whitehouse
openalex +1 more source
Ae Young Lee, Eungseok Oh
openaire +2 more sources
CLCN4‐Related Neurodevelopmental Condition: Characterization of Speech and Language Abilities
ABSTRACT Speech and language difficulties are a core feature of the CLCN4‐related neurodevelopmental condition, but these have not been well described. Here we systematically phenotype speech and language in 13 participants (10 female, aged 1 year 10 months–41 years 10 months) with pathogenic CLCN4 variants (12 missense de novo, 1 premature stop codon ...
Alexandra Garrett+4 more
wiley +1 more source
Hippocampal iron patterns in aging and mild cognitive impairment. [PDF]
Kagerer SM+7 more
europepmc +1 more source
PET Network Abnormalities and Cognitive Decline in Patients with Mild Cognitive Impairment [PDF]
Davangere P. Devanand+9 more
openalex +1 more source
Trisomy 5p: Long Recognized, Rarely Published‐ Three New Cases and Review of the Literature
ABSTRACT Complete trisomy 5p is a rare chromosomal disorder caused by a duplication of the short arm of chromosome 5. Current data suggest that complete trisomy 5p presents as a distinct clinical syndrome including but not limited to seizures, developmental delays, facial dysmorphisms, failure to thrive, and recurrent respiratory infections.
Gabriela J. Kim+2 more
wiley +1 more source